4.6 Editorial Material

Dysphagia caused by migrated mesh after paraesophageal hernia repair

Journal

ENDOSCOPY
Volume 43, Issue -, Pages E257-E258

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1055/s-0030-1256520

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

M. B. Maldonado-Perez, L. Castro-Laria, A. Caunedo-Alvarez, M. J. Montoya-Garcia, M. Giner-Garcia, F. Arguelles-Arias, M. Romero-Gomez, M. A. Vazquez-Gamez

JOURNAL OF CLINICAL DENSITOMETRY (2019)

Meeting Abstract Gastroenterology & Hepatology

Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study

I. Marin-Jimenez, G. Bastida, A. Fores, E. Garcia-Planella, F. Arguelles-Arias, P. Sarasa, I. Tagarro, A. Fernandez-Nistal, C. Montoto, M. Aguas, J. Santos-Fernandez, M. Bosca, R. Ferreiro-Iglesias, O. Merino, X. Aldeguer, X. Cortes, B. Sicilia, F. Mesonero, M. Barreiro-de Acosta

JOURNAL OF CROHNS & COLITIS (2019)

Meeting Abstract Gastroenterology & Hepatology

Polyphenolic extract from Chilean berry attenuates intestinal damage and improves clinical indicators in an animal model of Crohn's disease

T. Ortiz, J. -M. Garcia-Montes, F. Arguelles-Arias, M. Illanes, M. Guerra Veloz, M. Escoriza-Rodriguez, M. De Miguel

JOURNAL OF CROHNS & COLITIS (2019)

Meeting Abstract Gastroenterology & Hepatology

How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee

F. Casellas, D. Ginard, S. Garcia-Lopez, Y. Gonzalez-Lama, F. Arguelles-Arias, M. Barreiro-de Acosta, L. Marin Sanchez, J. M. Mendive, R. Saldana

JOURNAL OF CROHNS & COLITIS (2019)

Meeting Abstract Gastroenterology & Hepatology

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

G. Bastida, I. Marin-Jimenez, A. Fores, E. Garcia-Planella, F. Arguelles-Arias, P. Sarasa, I. Tagarro, A. Fernandez-Nistal, C. Montoto, M. Aguas, J. Santos-Fernandez, M. Bosca, R. Ferreiro-Iglesias, O. Merino, X. Aldeguer, X. Cortes, B. Sicilia, F. Mesonero, M. Barreiro-de Acosta

JOURNAL OF CROHNS & COLITIS (2019)

Meeting Abstract Gastroenterology & Hepatology

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registry

M. Calafat, M. Manosa, E. Ricart, E. Iglesias, M. Calvo, F. Rodriguez-Moranta, C. Taxonera, P. Nos, F. Mesonero, M. Martin-Arranz, M. Minguez, J. P. Gisbert, S. Garcia-Lopez, R. de Francisco, F. Gomollon, X. Calvet, E. Garcia-Planella, M. Rivero, J. Martinez-Cadila, F. Arguelles, L. Arias, M. Cimavilla, Y. Zabana, F. Canete, E. Cabre, E. Domenech

JOURNAL OF CROHNS & COLITIS (2019)

Article Gastroenterology & Hepatology

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Maria Jose Casanova, Maria Chaparro, Miguel Minguez, Elena Ricart, Carlos Taxonera, Santiago Garcia-Lopez, Jordi Guardiola, Antonio Lopez-San Roman, Eva Iglesias, Belen Beltran, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech, Xavier Calvet, Jose Lazaro Perez-Calle, Maria Dolores Martin-Arranz, Xavier Aldeguer, Montserrat Rivero, David Monfort, Jesus Barrio, Maria Esteve, Lucia Marquez, Rufo Lorente, Esther Garcia-Planella, Luisa de Castro, Fernando Bermejo, Olga Merino, Antonio Rodriguez-Perez, Pilar Martinez-Montiel, Manuel Van Domselaar, Guillermo Alcain, Manuel Dominguez-Cajal, Carmen Munoz, Fernando Gomollon, Luis Fernandez-Salazar, Mariana Fe Garcia-Sepulcre, Iago Rodriguez-Lago, Ana Gutierrez, Federico Arguelles-Arias, Cristina Rodriguez, Gloria Esther Rodriguez, Luis Bujanda, Jordina Llao, Pilar Varela, Laura Ramos, Jose Maria Huguet, Pedro Almela, Patricia Romero, Merce Navarro-Llavat, Agueda Abad, Patricia Ramirez-de la Piscina, Alfredo J. Lucendo, Eva Sese, Rosa Eva Madrigal, Mara Charro, Antonio Garcia-Herola, Ramon Pajares, Sam Khorrami, Javier P. Gisbert

INFLAMMATORY BOWEL DISEASES (2020)

Article Nutrition & Dietetics

Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn's Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways

Tamara Ortiz, Federico Arguelles-Arias, Matilde Illanes, Josefa-Maria Garcia-Montes, Elena Talero, Laura Macias-Garcia, Ana Alcudia, Victoria Vazquez-Roman, Virginia Motilva, Manuel De-Miguel

NUTRIENTS (2020)

Article Biochemistry & Molecular Biology

Native Chilean Berries Preservation and In Vitro Studies of a Polyphenol Highly Antioxidant Extract from Maqui as a Potential Agent against Inflammatory Diseases

Tamara Ortiz, Federico Arguelles-Arias, Belen Begines, Josefa-Maria Garcia-Montes, Alejandra Pereira, Montserrat Victoriano, Victoria Vazquez-Roman, Juan Luis Perez Bernal, Raquel M. Callejon, Manuel De-Miguel, Ana Alcudia

Summary: The study investigated the best conservation method for native Chilean berries and the application of maqui berry extract in intestinal epithelial and immune cells. The results demonstrate that the extract possesses strong antioxidant capacity and has the potential to treat inflammatory bowel disease.

ANTIOXIDANTS (2021)

Article Gastroenterology & Hepatology

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

Maria Chaparro, Iria Baston-Rey, Estela Fernandez-Salgado, Javier Gonzalez Garcia, Laura Ramos, Maria Teresa Diz-Lois Palomares, Federico Arguelles-Arias, Eva Iglesias Flores, Mercedes Cabello, Saioa Rubio Iturria, Andrea Nunez Ortiz, Mara Charro, Daniel Ginard, Carmen Duenas Sadornil, Olga Merino Ochoa, David Busquets, Eduardo Iyo, Ana Gutierrez Casbas, Patricia Ramirez de la Piscina, Marta Maia Bosca-Watts, Maite Arroyo, Maria Jose Garcia, Esther Hinojosa, Jordi Gordillo, Pilar Martinez Montiel, Benito Velayos Jimenez, Cristina Quilez Ivorra, Juan Maria Vazquez Moron, Jose Maria Huguet, Yago Gonzalez-Lama, Ana Isabel Munagorri Santos, Victor Manuel Amo, Maria Dolores Martin-Arranz, Fernando Bermejo, Jesus Martinez Cadilla, Cristina Rubin de Celix, Paola Fradejas Salazar, Antonio Lopez San Roman, Nuria Jimenez, Santiago Garcia Lopez, Anna Figuerola, Itxaso Jimenez, Francisco Jose Martinez Cerezo, Carlos Taxonera, Pilar Varela, Ruth de Francisco, David Monfort, Gema Molina Arriero, Alejandro Hernandez Camba, Francisco Javier Garcia-Alonso, Manuel Van Domselaar, Ramon Pajares Villarroya, Alejandro Nunez, Francisco Rodriguez Moranta, Ignacio Marin-Jimenez, Virginia Robles Alonso, Maria del Mar Martin Rodriguez, Patricia Camo-Monterde, Ivan Garcia Tercero, Mercedes Navarro Llavat, Lara Arias Garcia, Daniel Hervias Cruz, Sara Sulleiro, Cynthia Novella, Eugenia Vispo, Manuel Barreiro-de Acosta, Javier P. Gisbert

Summary: This large retrospective study demonstrates the effectiveness and safety of ustekinumab as a short- and long-term treatment option for patients with Crohn's disease in real-world clinical practice, including those with refractory disease.

INFLAMMATORY BOWEL DISEASES (2022)

Article Medicine, General & Internal

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Yamile Zabana, Ignacio Marin-Jimenez, Iago Rodriguez-Lago, Isabel Vera, Maria Dolores Martin-Arranz, Ivan Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benitez, Carlos Taxonera, Angel Ponferrada-Diaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Miriam Manosa, Pilar Martinez-Montiel, Maia Bosca-Watts, Jordi Gordillo, Luis Bujanda, Noemi Mancenido, Teresa Martinez-Perez, Alicia Lopez, Cristina Rodriguez-Gutierrez, Santiago Garcia-Lopez, Pablo Vega, Montserrat Rivero, Luigi Melcarne, Maria Calvo, Marisa Iborra, Manuel Barreiro de-Acosta, Beatriz Sicilia, Jesus Barrio, Jose Lazaro Perez, David Busquets, Isabel Perez-Martinez, Merce Navarro-Llavat, Vicent Hernandez, Federico Argueelles-Arias, Fernando Ramirez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollon, Fernando Munoz, Gerard Suris, Jone Ortiz de Zarate, Jose Maria Huguet, Jordina Llao, Mariana Fe Garcia-Sepulcre, Monica Sierra, Miguel Dura, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutierrez, Pilar Varela, Nuria Rull, Pau Gilabert, Alejandro Hernandez-Camba, Alicia Brotons, Daniel Ginard, Eva Sese, Daniel Carpio, Montserrat Aceituno, Jose Luis Cabriada, Yago Gonzalez-Lama, Laura Jimenez, Maria Chaparro, Antonio Lopez-San Roman, Cristina Alba, Rocio Plaza-Santos, Raquel Mena, Sonsoles Tamarit-Sebastian, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso-Galan, Ramon Pajares, Pablo Olcina, Pamela Manzano, Eugeni Domenech, Maria Esteve

Summary: This study describes the incidence and source of contagion of COVID-19 in patients with inflammatory bowel disease (IBD), as well as the risk factors for a severe course and long-term sequelae. The results show that the prognosis of COVID-19 in IBD patients, even in those on immunosuppression, is similar to that in the general population, indicating that there is no need for more strict protection measures in IBD.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab

Maria Chaparro, Iria Baston-Rey, Estela Fernandez Salgado, Javier Gonzalez Garcia, Laura Ramos, Maria Teresa Diz-Lois Palomares, Federico Arguelles-Arias, Eva Iglesias Flores, Mercedes Cabello, Saioa Rubio Iturria, Andrea Nunez Ortiz, Mara Charro, Daniel Ginard, Carmen Duenas Sadornil, Olga Merino Ochoa, David Busquets, Eduardo Iyo, Ana Gutierrez Casbas, Patricia Ramirez de la Piscina, Marta Maia Bosca-Watts, Maite Arroyo, Maria Jose Garcia, Esther Hinojosa, Jordi Gordillo, Pilar Martinez Montiel, Benito Velayos Jimenez, Cristina Quilez Ivorra, Juan Maria Vazquez Moron, Jose Maria Huguet, Yago Gonzalez-Lama, Ana Isabel Munagorri Santos, Victor Manuel Amo, Maria Dolores Martin Arranz, Fernando Bermejo, Jesus Martinez Cadilla, Cristina Rubin de Celix, Paola Fradejas Salazar, Antonio Lopez San Roman, Nuria Jimenez, Santiago Garcia-Lopez, Anna Figuerola, Itxaso Jimenez, Francisco Jose Martinez Cerezo, Carlos Taxonera, Pilar Varela, Ruth de Francisco, David Monfort, Gema Molina Arriero, Alejandro Hernandez-Camba, Francisco Javier Garcia Alonso, Manuel Van Domselaar, Ramon Pajares-Villarroya, Alejandro Nunez, Francisco Rodriguez Moranta, Ignacio Marin-Jimenez, Virginia Robles Alonso, Maria del Mar Martin Rodriguez, Patricia Camo-Monterde, Ivan Garcia Tercero, Mercedes Navarro-Llavat, Lara Arias Garcia, Daniel Hervias Cruz, Sebastian Kloss, Alun Passey, Cynthia Novella, Eugenia Vispo, Manuel Barreiro-de Acosta, Javier P. Gisbert

Summary: This study uses machine learning methods to explore potential influencing factors of Ustekinumab in the treatment of Crohn's Disease. The study found that less exposure to previous biologics has a positive effect on remission, and age, body mass index, and baseline fecal calprotectin are negative risk factors for both remission and drug survival.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

Yamile Zabana, Ignacio Marin-Jimenez, Iago Rodriguez-Lago, Isabel Vera, Maria Dolores Martin-Arranz, Ivan Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benitez, Carlos Taxonera, Angel Ponferrada-Diaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Miriam Manosa, Pilar Martinez-Montiel, Maia Bosca-Watts, Jordi Gordillo, Luis Bujanda, Noemi Mancenido, Teresa Martinez-Perez, Alicia Lopez, Cristina Rodriguez-Gutierrez, Santiago Garcia-Lopez, Pablo Vega, Montserrat Rivero, Luigi Melcarne, Maria Calvo, Marisa Iborra, Manuel Barreiro de Acosta, Beatriz Sicilia, Jesus Barrio, Jose Lazaro Perez Calle, David Busquets, Isabel Perez-Martinez, Merce Navarro-Llavat, Vicent Hernandez, Federico Arguelles-Arias, Fernando Ramirez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollon, Fernando Munoz, Gerard Suris, Jone Ortiz de Zarate, Jose Maria Huguet, Jordina Llao, Mariana Fe Garcia-Sepulcre, Monica Sierra, Miguel Dura, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutierrez, Pilar Varela, Nuria Rull, Pau Gilabert, Alejandro Hernandez-Camba, Alicia Brotons, Daniel Ginard, Eva Sese, Daniel Carpio, Montserrat Aceituno, Jose Luis Cabriada, Yago Gonzalez-Lama, Laura Jimenez, Maria Chaparro, Antonio Lopez-San Roman, Cristina Alba, Rocio Plaza-Santos, Raquel Mena, Sonsoles Tamarit-Sebastian, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso-Galan, Ramon Pajares, Pablo Olcina, Pamela Manzano, Eugeni Domenech, Maria Esteve

Summary: Comorbidities and occupational exposure are the most relevant factors for COVID-19 in patients with IBD. The risk of COVID-19 does not seem to be increased by immunosuppressants or biologics, but there may be a potential effect of 5-aminosalicylates that requires further investigation.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

Maria Fernanda Guerra Veloz, Maria Belvis Jimenez, Teresa Valdes Delgado, Luisa Castro Laria, Belen Maldonado Perez, Raul Perea Amarillo, Vicente Merino Bohorquez, Angel Caunedo Alvarez, Angel Vilches Arenas, Federico Arguelles-Arias

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)

Meeting Abstract Gastroenterology & Hepatology

Clinical follow-up of patients with Crohn's disease treated with ustekinumab in our hospital

T. Valdes Delgado, C. A. Moreno Marquez, M. F. Guerra Veloz, L. Castro Laria, B. Maldonado Perez, V. Merino Bohorquez, F. Arguelles Arias

JOURNAL OF CROHNS & COLITIS (2019)

No Data Available